Markus Warmuth insider trades

Open-market stock purchases and sales by Markus Warmuth, President & CEO at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Apr 12, 2021.

Recent trades

DateStockTradeValue
Jun 1, 2026GLUE Monte Rosa Therapeutics, IncSold$97K
Jun 1, 2026GLUE Monte Rosa Therapeutics, IncSold$9.2K
May 1, 2026GLUE Monte Rosa Therapeutics, IncSold$103K
Apr 14, 2026GLUE Monte Rosa Therapeutics, IncSold$141K
Mar 2, 2026GLUE Monte Rosa Therapeutics, IncSold$98K
Jan 7, 2026GLUE Monte Rosa Therapeutics, IncSold$86.2K
Jan 7, 2026GLUE Monte Rosa Therapeutics, IncSold$34.6K
Jan 7, 2026GLUE Monte Rosa Therapeutics, IncSold$7.6K
Jan 5, 2026GLUE Monte Rosa Therapeutics, IncSold$154K
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—

Companies traded

  • GLUE Monte Rosa Therapeutics, Inc: 9 sales, last Jun 1, 2026

Get free alerts when Markus Warmuth files a new trade →